Global Pharmaceuticals & Biotech Big Green Snowflakes

Jianmin Pharmaceutical GroupLtd

Market Cap: CN¥6.7b

Manufactures and sells medicines in China.

Zhejiang Haisen Pharmaceutical

Market Cap: CN¥3.8b

Engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China.

Beijing Foyou PharmaLTD

Market Cap: CN¥10.9b

Engages in the research and development, production, and sale of pharmaceutical preparations and medical equipment.

JSP Pharmaceutical Manufacturing (Thailand) Public

Market Cap: ฿878.0m

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

L&C BIOLTD

Market Cap: ₩1.2t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

Ocumension Therapeutics

Market Cap: HK$8.5b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Hua Medicine (Shanghai)

Market Cap: HK$4.3b

Engages in the development and commercialization of drugs for the treatment of diabetes in China.

Imexpharm

Market Cap: ₫8.5t

Manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally.

Sai Life Sciences

Market Cap: ₹178.0b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

TCM Biotech International

Market Cap: NT$6.6b

A biotech company, engages in the research and development of drugs for liver diseases.

Hefei Lifeon Pharmaceutical

Market Cap: CN¥6.0b

Engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients.

Suzhou Sepax Technologies

Market Cap: CN¥7.7b

Researches, develops, produces, and sells liquid chromatography materials for the separation and purification of biomacromolecules and other drugs worldwide.

Haleos Labs

Market Cap: ₹3.5b

Manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.

PharmaCyte Biotech

Market Cap: US$6.4m

A biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.

Valneva

Market Cap: €614.8m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Capricor Therapeutics

Market Cap: US$308.1m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Avantor

Market Cap: US$9.1b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Olema Pharmaceuticals

Market Cap: US$570.4m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Sprint Bioscience

Market Cap: SEK 64.4m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Vanda Pharmaceuticals

Market Cap: US$272.4m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Aldeyra Therapeutics

Market Cap: US$333.0m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

4D Molecular Therapeutics

Market Cap: US$339.5m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

High Tide

Market Cap: CA$385.7m

Engages in the cannabis retail business in Canada.

Bone Biologics

Market Cap: US$4.1m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

SAB Biotherapeutics

Market Cap: US$23.6m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

ProKidney

Market Cap: US$662.1m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Stevanato Group

Market Cap: US$6.6b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Tenaya Therapeutics

Market Cap: US$220.0m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Travere Therapeutics

Market Cap: US$1.9b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Verastem

Market Cap: US$662.8m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Ouro Fino Saúde Animal Participações

Market Cap: R$1.2b

Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.

Radiopharm Theranostics

Market Cap: AU$68.6m

Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.

Zhejiang Benli Technology

Market Cap: CN¥2.5b

Engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally.

Alpa Laboratories

Market Cap: ₹2.0b

Engages in the manufacture and sale of pharmaceutical finished dosage forms in India.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.7b

Shanghai Rightongene Biotechnology Co., Ltd.